| Corace has received funding from the [[Canadian Institutes of Health Research]] (CIHR) and the [[Canadian Centre on Substance Use and Addiction]] (CCSA).((Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Esmaeilisaraji, L., Skidmore, B., Porath, A., Ortiz Nunez, R., & Hutton, B. (2020). //Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature.// Systematic Reviews, 9(1). https://doi.org/10.1186/s13643-020-01499-z)) ((Wolfe, D., Corace, K., Rice, D., Smith, A., Kanji, S., Conn, D., Willows, M., Garber, G. E., Puxty, J., Moghadam, E., Skidmore, B., Garritty, C., Thavorn, K., Moher, D., & Hutton, B. (2020). //Effects of medical and non-medical cannabis use in older adults: protocol for a scoping review.// BMJ Open, 10(2), e034301. https://doi.org/10.1136/bmjopen-2019-034301)) | Corace has received funding from the [[Canadian Institutes of Health Research]] (CIHR) and the [[Canadian Centre on Substance Use and Addiction]] (CCSA).((Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Esmaeilisaraji, L., Skidmore, B., Porath, A., Ortiz Nunez, R., & Hutton, B. (2020). //Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature.// Systematic Reviews, 9(1). https://doi.org/10.1186/s13643-020-01499-z)) ((Wolfe, D., Corace, K., Rice, D., Smith, A., Kanji, S., Conn, D., Willows, M., Garber, G. E., Puxty, J., Moghadam, E., Skidmore, B., Garritty, C., Thavorn, K., Moher, D., & Hutton, B. (2020). //Effects of medical and non-medical cannabis use in older adults: protocol for a scoping review.// BMJ Open, 10(2), e034301. https://doi.org/10.1136/bmjopen-2019-034301)) |
| She has received various forms of funding from [[pharmaceutical_companies:Janssen]], [[Reckitt Benckiser]], and [[pharmaceutical_companies:Vertex Pharmaceuticals]].((Rouleau, C. R., Lavoie, K. L., Bacon, S. L., Vallis, M., Corace, K., & Campbell, T. S. (2015). //Training Healthcare Providers in Motivational Communication for Promoting Physical Activity and Exercise in Cardiometabolic Health Settings: Do We Know What We Are Doing?// Current Cardiovascular Risk Reports, 9(6). https://doi.org/10.1007/s12170-015-0457-2)) | She has received various forms of funding from [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Novo Nordisk]], [[Reckitt Benckiser]], and [[pharmaceutical_companies:Vertex Pharmaceuticals]].((Rouleau, C. R., Lavoie, K. L., Bacon, S. L., Vallis, M., Corace, K., & Campbell, T. S. (2015). //Training Healthcare Providers in Motivational Communication for Promoting Physical Activity and Exercise in Cardiometabolic Health Settings: Do We Know What We Are Doing?// Current Cardiovascular Risk Reports, 9(6). https://doi.org/10.1007/s12170-015-0457-2)) ((Corace, K. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220503021854/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Kim-Corace_20211006.pdf)) |
